 ?您的位置：對照品 > 標準物質 > 標準樣品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：T012635 |
| 產(chǎn)品名稱：TCS 1102 |
| 產(chǎn)品CAS：916141-36-1 |
| 規(guī)格含量：5mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細介紹 |
| 標準品編號: |
T012635 |
| 名稱: |
TCS 1102 |
| 別名: |
(2S)-N-[1,1'-Biphenyl]-2-yl-1-[2-[(1-methyl-1H-benzimidazol-2-yl)thio]acetyl]-2-pyrrolidinecarboxamide; |
| CAS號: |
916141-36-1 |
| 分子式: |
C??H??N?O?S |
| 分子量: |
470.59 |
| 類別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應用: |
TCS 1102 is a dual antagonist of both OX1R and OX2R. It is a poor substrate for P-glycoprotein and, as a result, demonstrates good brain penetration when administered intraperitoneally. Dual orexin receptor antagonists, including TCS 1102, promote sleep and prevent drug-induced plasticity and drug relapse. |
| 參考文獻 |
|
|
|
|
|
|
